Category : News & Events

Mucsi-Novak Group

Increased Risk of CKD and Mortality in Diabetic Patients With Depression

The impact of mental illness on renal outcomes has been insufficiently documented in diabetic patient populations. Our team’s study, recently published in the Diabetes Care journal of the American Diabetes Association, examined whether comorbid depression in diabetic patients is linked to an increased risk of Chronic Kidney Disease (CKD). The study concluded that the presence of depression was associated with a 20% higher risk of developing CKD, as well as an increased all-cause mortality. Effective mental health interventions may therefore […]

Launch of the ETO program

Explore Transplant Ontario Program

To address the lack of transplant education in Ontario, Dr. Mucsi and Dr. Novak teamed up with Dr. Amy Waterman, creator of the widely successful program ‘Explore Transplant’. The program, which was developed by Dr. Waterman at UCLA, aims to dispel myths and misconceptions and explain the transplant process from both medical and past patients’ perspectives. Explore Transplant helps patients and potential donors make informed, knowledgeable, and empowered decisions about their health and treatment options. Dr. Mucsi and Dr. Novak then worked to […]

Mucsi-Novak Group

Explore Transplant Ontario pilot study (UHN 16-5314-AE)

The Explore Transplant Ontario (ETO) pilot study assessed the feasibility and efficacy of ETO, a transplant education package, to improve transplant-related knowledge and transplant readiness among patients who have end-stage kidney disease (ESKD) and are receiving dialysis. This 2016-2017 study was conducted at the dialysis units of University Health Network and Humber River Hospital. The study was designed by Drs. Mucsi and Novak of UHN and Dr. Amy Waterman, a psychologist and health education researcher from UCLA. The original Explore […]

Mucsi-Novak Group

Validation of the PROMIS-57. PROMIS-43 and PROMIS-29 Profile in Patients with Chronic Kidney Disease (UHN 15-9645-AE)

Patient-reported outcomes (PROs), such as symptoms, health- related quality of life (HRQOL), or satisfaction with care, are reported directly by the patient, without interpretation by the clinician or a family member/caregiver. These outcomes inform clinicians and researchers about patient’s challenges and sources of suffering, and they provide information that supplements “traditional” clinical outcomes, such as mortality or hospitalization. PROs are valued by patients, clinicians, and policy-makers. They inform therapeutic choices, disease management practices, reimbursement decisions, and health policy. Recently, the […]

Mucsi-Novak Group

Systematic screening guided management of psychosocial distress to reduce distress, to improve Health Related Quality of Life and to facilitate access to psychosocial care among patients with advanced chronic kidney disease

We are planning a study to test the following primary hypothesis: a systematic, screening guided management of psychosocial distress in patients with advanced chronic kidney disease (CKD) will reduce psychosocial distress and improve health related quality of life. Patients CKD experience a wide range of psychosocial stressors in relation to the intrusiveness of both their underlying medical condition and the intrusive nature of the renal replacement therapies, including maintenance dialysis. Clearly, these stressors also have an impact on the family […]